Save up to 90% on Victoza with Coupons, Discount Cards & Patient Assistance Programs

Victoza is the brand name for liraglutide and is available as a subcutaneous injection.

Victoza is available as a 6 mg/mL solution in a pre-filled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg.

Victoza is a GLP-1 agonist and is used for the following:

• Type 2 diabetes in people age 10 and older, in addition to diet and exercise
• Lowering the risk of major heart-related problems (like heart attack) in adults with Type 2 diabetes and heart disease

Victoza is a glucagon-like peptide-1 receptor agonist, or GLP-1 agonist for short. It attaches to proteins in your body called GLP-1 receptors. Once attached, the medication tells your body to release more insulin. It also helps stop the body from releasing more sugar and slow down digestion. All three actions of Victoza help lower blood sugar levels.

Victoza is injected under the skin on the stomach, thigh, or back of the upper arm. The typical starting dose is 0.6 mg once daily. After at least 1 week at the starting dose, your provider might raise the dose to 1.2 mg once daily. If you need additional blood sugar control, your provider can raise the dose again to 1.8 mg once daily.

Victoza is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if you have the following:

• Have a personal or family history of medullary thyroid carcinoma (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)

Common side effects of Victoza:

• Nausea
• Diarrhea
• Headache
• Common cold symptoms
• Vomiting
• Poor appetite
• Indigestion

Serious side effects are rare with Victoza. Contact your healthcare provider immediately if you experience any of the following.

• Allergic reaction: hives, difficulty breathing, swelling of the face or throat
• Pancreatitis or gallstones: severe stomach or back pain, vomiting, yellowing of the skin or eyes

The following medications may interact with Victoza:

• Effects of delayed gastric emptying on oral medications: Victoza delays gastric emptying and may impact absorption of concomitantly administered oral medications

Novo Nordisk Inc.

It is not known if Victoza will harm your unborn baby. Tell your healthcare provider if you become pregnant while using Victoza.

• Liraglutide